Centessa Pharmaceuticals plc
- CNTA
- NASDAQ
- Biotechnology
- Rare Disease Therapeutics
- Clinical-stage Biotech
$40.50
Quote Jun 25, 2026, 08:00 PM UTC
+1.73%over the last month
Max drawdown −0.7%From 1-month high 0.0%3 months +41.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$6.27B
Quote Jun 25
Next earnings
—
Data unavailable
Analyst target
$42.00
+3.7% from here
Floor
$40.41
0.2% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CNTAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
129